New insights into the mechanism of action of soluble klotho

George D. Dalton, Jian Xie, Sung Wan An, Chou Long Huang

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

The klotho gene encodes a type I single-pass transmembrane protein that contains a large extracellular domain, a membrane spanning segment, and a short intracellular domain. Klotho protein exists in several forms including the full-length membrane form (mKl) and a soluble circulating form [soluble klotho (sKl)]. mKl complexes with fibroblast growth factor receptors to form coreceptors for FGF23, which allows it to participate in FGF23-mediated signal transduction and regulation of phosphate and calcium homeostasis. sKl is present in the blood, urine, and cerebrospinal fluid where it performs a multitude of functions including regulation of ion channels/transporters and growth factor signaling. How sKl exerts these pleiotropic functions is poorly understood. One hurdle in understanding sKl's mechanism of action as a "hormone" has been the inability to identify a receptor that mediates its effects. In the body, the kidneys are a major source of sKl and sKl levels decline during renal disease. sKl deficiency in chronic kidney disease makes the heart susceptible to stress-induced injury. Here, we summarize the current knowledge of mKl's mechanism of action, the mechanistic basis of sKl's protective, FGF23-independent effects on the heart, and provide new insights into the mechanism of action of sKl focusing on recent findings that sKl binds sialogangliosides in membrane lipid rafts to regulate growth factor signaling.

Original languageEnglish (US)
Article number323
JournalFrontiers in Endocrinology
Volume8
Issue numberNOV
DOIs
StatePublished - Nov 17 2017

Fingerprint

Intercellular Signaling Peptides and Proteins
Kidney
Fibroblast Growth Factor Receptors
Membranes
Membrane Lipids
Chronic Renal Insufficiency
Ion Channels
Cerebrospinal Fluid
Signal Transduction
Homeostasis
Urine
Hormones
Wounds and Injuries
Genes
Proteins
calcium phosphate
sialogangliosides
klotho protein

Keywords

  • Aging
  • FGF23
  • Heart disease
  • IGF-1
  • Klotho
  • Lipid rafts
  • Sialidase
  • TRPC6

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

New insights into the mechanism of action of soluble klotho. / Dalton, George D.; Xie, Jian; An, Sung Wan; Huang, Chou Long.

In: Frontiers in Endocrinology, Vol. 8, No. NOV, 323, 17.11.2017.

Research output: Contribution to journalReview article

Dalton, George D. ; Xie, Jian ; An, Sung Wan ; Huang, Chou Long. / New insights into the mechanism of action of soluble klotho. In: Frontiers in Endocrinology. 2017 ; Vol. 8, No. NOV.
@article{e4c1902d9ca146f298938c6b3feba26a,
title = "New insights into the mechanism of action of soluble klotho",
abstract = "The klotho gene encodes a type I single-pass transmembrane protein that contains a large extracellular domain, a membrane spanning segment, and a short intracellular domain. Klotho protein exists in several forms including the full-length membrane form (mKl) and a soluble circulating form [soluble klotho (sKl)]. mKl complexes with fibroblast growth factor receptors to form coreceptors for FGF23, which allows it to participate in FGF23-mediated signal transduction and regulation of phosphate and calcium homeostasis. sKl is present in the blood, urine, and cerebrospinal fluid where it performs a multitude of functions including regulation of ion channels/transporters and growth factor signaling. How sKl exerts these pleiotropic functions is poorly understood. One hurdle in understanding sKl's mechanism of action as a {"}hormone{"} has been the inability to identify a receptor that mediates its effects. In the body, the kidneys are a major source of sKl and sKl levels decline during renal disease. sKl deficiency in chronic kidney disease makes the heart susceptible to stress-induced injury. Here, we summarize the current knowledge of mKl's mechanism of action, the mechanistic basis of sKl's protective, FGF23-independent effects on the heart, and provide new insights into the mechanism of action of sKl focusing on recent findings that sKl binds sialogangliosides in membrane lipid rafts to regulate growth factor signaling.",
keywords = "Aging, FGF23, Heart disease, IGF-1, Klotho, Lipid rafts, Sialidase, TRPC6",
author = "Dalton, {George D.} and Jian Xie and An, {Sung Wan} and Huang, {Chou Long}",
year = "2017",
month = "11",
day = "17",
doi = "10.3389/fendo.2017.00323",
language = "English (US)",
volume = "8",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media S. A.",
number = "NOV",

}

TY - JOUR

T1 - New insights into the mechanism of action of soluble klotho

AU - Dalton, George D.

AU - Xie, Jian

AU - An, Sung Wan

AU - Huang, Chou Long

PY - 2017/11/17

Y1 - 2017/11/17

N2 - The klotho gene encodes a type I single-pass transmembrane protein that contains a large extracellular domain, a membrane spanning segment, and a short intracellular domain. Klotho protein exists in several forms including the full-length membrane form (mKl) and a soluble circulating form [soluble klotho (sKl)]. mKl complexes with fibroblast growth factor receptors to form coreceptors for FGF23, which allows it to participate in FGF23-mediated signal transduction and regulation of phosphate and calcium homeostasis. sKl is present in the blood, urine, and cerebrospinal fluid where it performs a multitude of functions including regulation of ion channels/transporters and growth factor signaling. How sKl exerts these pleiotropic functions is poorly understood. One hurdle in understanding sKl's mechanism of action as a "hormone" has been the inability to identify a receptor that mediates its effects. In the body, the kidneys are a major source of sKl and sKl levels decline during renal disease. sKl deficiency in chronic kidney disease makes the heart susceptible to stress-induced injury. Here, we summarize the current knowledge of mKl's mechanism of action, the mechanistic basis of sKl's protective, FGF23-independent effects on the heart, and provide new insights into the mechanism of action of sKl focusing on recent findings that sKl binds sialogangliosides in membrane lipid rafts to regulate growth factor signaling.

AB - The klotho gene encodes a type I single-pass transmembrane protein that contains a large extracellular domain, a membrane spanning segment, and a short intracellular domain. Klotho protein exists in several forms including the full-length membrane form (mKl) and a soluble circulating form [soluble klotho (sKl)]. mKl complexes with fibroblast growth factor receptors to form coreceptors for FGF23, which allows it to participate in FGF23-mediated signal transduction and regulation of phosphate and calcium homeostasis. sKl is present in the blood, urine, and cerebrospinal fluid where it performs a multitude of functions including regulation of ion channels/transporters and growth factor signaling. How sKl exerts these pleiotropic functions is poorly understood. One hurdle in understanding sKl's mechanism of action as a "hormone" has been the inability to identify a receptor that mediates its effects. In the body, the kidneys are a major source of sKl and sKl levels decline during renal disease. sKl deficiency in chronic kidney disease makes the heart susceptible to stress-induced injury. Here, we summarize the current knowledge of mKl's mechanism of action, the mechanistic basis of sKl's protective, FGF23-independent effects on the heart, and provide new insights into the mechanism of action of sKl focusing on recent findings that sKl binds sialogangliosides in membrane lipid rafts to regulate growth factor signaling.

KW - Aging

KW - FGF23

KW - Heart disease

KW - IGF-1

KW - Klotho

KW - Lipid rafts

KW - Sialidase

KW - TRPC6

UR - http://www.scopus.com/inward/record.url?scp=85034648271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034648271&partnerID=8YFLogxK

U2 - 10.3389/fendo.2017.00323

DO - 10.3389/fendo.2017.00323

M3 - Review article

C2 - 29250031

AN - SCOPUS:85034648271

VL - 8

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

IS - NOV

M1 - 323

ER -